Purchase Order 75N98021P01737
Award Date
5/20/21
Potential Completion Date
6/21/21
Potential Value
$92K
Funding Federal Agency
National Eye Institute
Contracting Federal Agency
Office of Logisitics and Acquisition Operations
Awardee
Diagenode, LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Denville, NJ 07834, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Eye Institute awarded a $146,400 purchase order to Diagenode, LLC for laboratory testing services. As a prime contractor, Diagenode will provide the requested testing services to the NIH NEI under a firm fixed price contract over a one year period of performance starting August 31, 2023 through August 30, 2024 at its facility in Denville, New Jersey. No major subcontractors or set aside designations were...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Eye Institute to Diagenode, LLC, a for-profit limited liability company, for epigenetics research and biological sample preparations. The $37,441.44 contract has a completion date of May 21, 2025 and does not utilize a set-aside designation. Diagenode is a global leader in epigenetics research, offering specialized instruments, reagents, and analytical...
This firm fixed-price purchase order for $201,600 was awarded by the National Institutes of Health's National Eye Institute to Diagenode, LLC for genome wide methylation services using the Infinium Methylation EPIC v.2.0 BeadChip. The award continues work initiated under a previous contract to process 480 samples for the agency's research within the specified one-year period of performance. As the sole provider capable of ensuring continuity of data generation and cross-comparison between the...
The National Eye Institute (NEI), a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed-price purchase order to Illumina, Inc. for a NextSeq 2000 Silver Support Service contract. The $234,450.00 contract provides annual software license and maintenance support for the NextSeq 2000 scientific sequencing instrument, which is exclusively manufactured and serviced by Illumina. The contract does not have a set-aside designation. This award aligns with NEI's genomic...
The U.S. National Eye Institute (NEI) awarded a $12,300.00 Firm Fixed Price Purchase Order to Creative Biolabs Inc., a specialized biotechnology and pharmaceutical services provider. The contract, which does not have a set-aside designation, supports the NEI's research efforts by providing a range of services including antibody production, cell line development, protein engineering, and related areas. Key deliverables include single domain antibody clones, custom T cell receptor-Jurkat cell...
The federal agency National Eye Institute (NEI) awarded a $15,600 firm fixed price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that supports biomedical research. The contract is for the NANODROP EIGHT (GLOBAL) product and does not have a set-aside designation. This purchase order is associated with a larger Indefinite Delivery Vehicle contract that Life Technologies holds with the NEI, which streamlines the acquisition of...
The National Eye Institute (NEI), part of the National Institutes of Health (NIH), has awarded a $29,096 firm-fixed-price purchase order to Medrio, Inc. to provide an electronic informed consent (e-consent) platform. This procurement is to support the eyeGENE clinical research program, which aims to advance studies of eye diseases and their genetic causes. The e-consent platform will allow NEI to re-consent over 6,400 existing eyeGENE participants to expand the scope of research use of their...
The National Institutes of Health (NIH) National Institute on Aging (NIA) awarded a $25,805.25 firm-fixed-price purchase order to Diagenode, LLC, a global life sciences company, for the procurement of a Bioruptor Plus DNA shearing instrument and related accessories. This non-competitive acquisition was conducted under simplified acquisition procedures and was not set aside for small businesses. The requirement was for specialized laboratory equipment needed to support epigenetics research...
The Department of Health and Human Services' National Institutes of Health National Eye Institute awarded a $14,896 firm fixed price purchase order to Qiagen, LLC. Qiagen will provide products or services to the NIH/NEI under this award, which runs from August 2023 through August 2024. The prime contractor Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. No major...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Eye Institute (NEI) awarded a Firm-Fixed-Price purchase order to Microbrightfield, LLC, doing business as Microbrightfield Inc., to upgrade and customize a specialized MicroBrightField Image Acquisition and Analysis System (MIAAS) microscope and software. The $137,306.00 contract will update the microscope stage, light source, cameras, and software to enhance imaging capabilities and integrate image...